The American Society of Tropical Medicine and Hygiene has waived the Open Access fee for this article due to the ongoing COVID-19 pandemic.
Starr TN et al., 2021. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371: 850–854.
United States Food and Drug Administration , 2021. Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab and Etesevimab. Available at: https://www.fda.gov/media/145802.
Davies NG et al., 2021. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 372: eabg3055.
Frampton D et al., 2021. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis. doi: 10.1016/S1473-3099(21)00170-5.
Oster AM, Caruso E, DeVies J, Hartnett KP, Boehmer TK, 2020. Transmission dynamics by age group in COVID-19 hotspot counties—United States, April–September 2020. MMWR Morb Mortal Wkly Rep 69: 1494–1496.